TGFB1 and neoplasm: Importantly, the low frequency of MSI-high tumors among the H/L EOCRC patients suggests that the distinct molecular alterations observed in WNT, TGF-β, and RTK/RAS pathways in this group are likely driven by microsatellite-stable tumor biology.